Renomedullary Interstitial Cell Endothelin A Receptors Regulate BP and Renal Function

Abstract

BackgroundThe physiologic role of renomedullary interstitial cells, which are uniquely and abundantly found in the renal inner medulla, is largely unknown. Endothelin A receptors regulate multiple aspects of renomedullary interstitial cell function in vitro.MethodsTo assess the effect of targeting renomedullary interstitial cell endothelin A receptors in vivo, we generated a mouse knockout model with inducible disruption of renomedullary interstitial cell endothelin A receptors at 3 months of age.ResultsBP and renal function were similar between endothelin A receptor knockout and control mice during normal and reduced sodium or water intake. In contrast, on a high-salt diet, compared with control mice, the knockout mice had reduced BP; increased urinary sodium, potassium, water, and endothelin-1 excretion; increased urinary nitrite/nitrate excretion associated with increased noncollecting duct nitric oxide synthase-1 expression; increased PGE2 excretion associated with increased collecting duct cyclooxygenase-1 expression; and reduced inner medullary epithelial sodium channel expression. Water-loaded endothelin A receptor knockout mice, compared with control mice, had markedly enhanced urine volume and reduced urine osmolality associated with increased urinary endothelin-1 and PGE2 excretion, increased cyclooxygenase-2 protein expression, and decreased inner medullary aquaporin-2 protein content. No evidence of endothelin-1–induced renomedullary interstitial cell contraction was observed.ConclusionsDisruption of renomedullary interstitial cell endothelin A receptors reduces BP and increases salt and water excretion associated with enhanced production of intrinsic renal natriuretic and diuretic factors. These studies indicate that renomedullary interstitial cells can modulate BP and renal function under physiologic conditions.

Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice

“…Db/db mice were injected retro-orbitally with FITC-sinistrin (7 mg 100 g −1 body weight; MediBeacon, Germany). A miniaturized imager device (MediBeacon) was used to detect fluorescence in the skin on the shaved back over 1 h. GFR was calculated on the basis of the kinetics of fluorescence decay 46 . n = 4 in Db/m and Db/db group, n = 6 in Db + Ato10 group.…”